This inventor holds 1 USPTO granted patent. Top assignee: Mundipharma Ag. Active years: 1979.
Company Filing History:
Years Active: 1979
Title: John Kelly - Innovator in Pharmaceutical Chemistry
Introduction
John Kelly is a notable inventor and Personal Representative based in Great Saukey, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on stabilized choline salicylate compounds. His research has implications for the stability and efficacy of pharmaceutical preparations.
Latest Patents
John Kelly holds 1 patent for his invention related to stabilized choline salicylate compounds. The patent describes choline salicylate sulfite and choline salicylate alkali metal sulfite-containing compounds, which are characterized by the formula where Me represents sodium, potassium, or lithium ions, and R represents various sulfite groups. These compounds are noted for their stability and ability to inhibit color formation in pharmaceutical preparations, enhancing their usability and effectiveness.
Career Highlights
Throughout his career, John Kelly has been associated with Mundipharma AG, where he has applied his expertise in pharmaceutical chemistry. His work has contributed to advancements in drug formulation and stability, making a positive impact on the industry.
Collaborations
John has collaborated with notable individuals in his field, including William Kelly, who is now deceased, and Alfred Halpein. These collaborations have enriched his research and contributed to the development of innovative pharmaceutical solutions.
Conclusion
John Kelly's contributions to the field of pharmaceutical chemistry through his patent on stabilized choline salicylate compounds highlight his role as an innovator. His work continues to influence the development of stable and effective pharmaceutical preparations.